Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
27 1월 2024 - 6:08AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check the Appropriate Box:
☐ |
Preliminary Proxy Statement |
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ |
Definitive Proxy Statement |
☒ |
Definitive Additional Materials |
☐ |
Soliciting Material Under Rule 14a-12 |
Citius Pharmaceuticals,
Inc.
(Name of Registrant as Specified
in Its Charter)
(Name of Person(s) Filing Proxy Statement if other
than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☒ |
No fee required. |
|
|
☐ |
Fee paid previously with preliminary materials: |
|
|
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Citius Pharmaceuticals (NASDAQ:CTXR)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Citius Pharmaceuticals (NASDAQ:CTXR)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024